Investors are on the edge of their collective seats, hoping that Intuitive Surgical
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Intuitive Surgical with nine of 14 analysts rating it hold. Analysts don't like Intuitive Surgical as much as competitor Stryker overall. Twenty-one out of 27 analysts rate Stryker a buy compared to five of 14 for Intuitive Surgical. While analysts still rate the stock a Hold, they are a little more optimistic about it compared to three months ago.
- Revenue Forecasts: On average, analysts predict $417.8 million in revenue this quarter. That would represent a rise of 21.3% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $2.76 per share. Estimates range from $2.67 to $2.89.
What our community says:
CAPS All Stars are solidly behind the stock with 96.9% assigning it an "outperform" rating. The community at large agrees with the All Stars with 95.3% giving it a rating of "outperform." Fools have embraced Intuitive Surgical and haven't been shy with their opinions lately, logging 1,432 posts in the past 30 days. Even with a robust four out of five stars, Intuitive Surgical's CAPS rating falls a little short of the community's upbeat outlook.
Intuitive Surgical's profit has risen year over year by an average of 36.2% over the past five quarters.
For all our Intuitive Surgical-specific analysis, including earnings and beyond, add Intuitive Surgical to My Watchlist.
Motley Fool newsletter services have recommended buying shares of Intuitive Surgical.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.